{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:45:31Z","timestamp":1792421131544,"version":"4.5.0"},"reference-count":23,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Complex Program of Basic Research under the Siberian Branch of the Russian Academy of Sciences","award":["0419-2022-0002"],"award-info":[{"award-number":["0419-2022-0002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Patients with type 2 diabetes make up 25 to 40% of those referred for coronary bypass surgery, and the impact of diabetes on the results of the operation is studied in various aspects. To assess the state of carbohydrate metabolism before any surgical interventions, including CABG, daily glycemic control, and the determination of glycated hemoglobin (HbA1c) is recommended. Glycated hemoglobin reflects the glucose concentration for the 3 months prior to the measurement, but alternative markers that reflect glycemic fluctuations over a shorter period of time may be useful in preoperative preparation. The aim of this study was to study the relationship between the concentration of alternative markers of carbohydrate metabolism (fructosamine and 1,5-anhydroglucitol) with patients\u2019 clinical characteristics and the rate of hospital complications after coronary artery bypass grafting (CABG). Method. In the cohort of 383 patients, besides the routine examination, additional markers of carbohydrate metabolism were determined before and on days 7\u20138 after CABG: glycated hemoglobin (HbA1c), fructosamine, and 1,5-anhydroglucitol. We evaluated the dynamics of these parameters in groups of patients with diabetes mellitus, prediabetes, and normoglycemia, as well as the association of these parameters with clinical parameters. Additionally, we assessed the incidence of postoperative complications and factors associated with their development. Results. In all groups of patients (diabetes mellitus, prediabetes, normoglycemia), there was a significant decrease in the level of fructosamine on the 7th day after CABG compared with baseline (p1st\u20132nd point 0.030, 0.001, and 0.038 in groups 1, 2, and 3, respectively), whereas the level of 1,5-anhydroglucitol did not change significantly. The preoperative level of fructosamine was associated with the risk of surgery according to the EuroSCORE II scale (p = 0.002), as were the number of bypasses (p = 0.012), body mass index and overweightness (p &lt; 0.001 in both cases), triglyceride (p &lt; 0.001) and fibrinogen levels (p = 0.002), preoperative and postoperative glucose and HbA1c levels (p &lt; 0.001 in all cases), left atrium size (p = 0.028), multiplicity of cardioplegia, cardiopulmonary bypass duration and aortic clamp time (p &lt; 0.001 in all cases). The preoperative level of 1,5-anhydroglucitol showed an inverse correlation with fasting glucose and fructosamine levels before surgery (p &lt; 0.001 in all cases), intima media thickness (p = 0.016), and a direct correlation with LV end-diastolic volume (p = 0.020). The combined endpoint (presence of significant perioperative complications + extended hospital stay after surgery &gt;10 days) was identified in 291 patients. In binary logistic regression analysis patient age (p = 0.005) and fructosamine level (p = 0.022) were independently associated with the development of this composite endpoint (presence of significant perioperative complications + extended hospital stay after surgery &gt;10 days). Conclusions: This study demonstrated that in patients after CABG there was the significant decrease in the level of fructosamine compared with baseline, whereas the level of 1,5-anhydroglucitol did not change. Preoperative fructosamine levels were one of the independent predictors of the combined endpoint. The prognostic value of preoperative assessment of alternative markers of carbohydrate metabolism in cardiac surgery deserves further study.<\/jats:p>","DOI":"10.3390\/diagnostics13050969","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T06:29:06Z","timestamp":1678084146000},"page":"969","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Alternative Markers of Carbohydrate Metabolism (Fructosamine and 1,5-Anhydroglucitol) with Perioperative Characteristics and In-Hospital Complications of Coronary Artery Bypass Grafting in Patients with Type 2 Diabetes Mellitus, Prediabetes, and Normoglycemia"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-4793","authenticated-orcid":false,"given":"Alexey N.","family":"Sumin","sequence":"first","affiliation":[{"name":"Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Blvd. 6, Kemerovo 650002, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9396-4575","authenticated-orcid":false,"given":"Natalia A.","family":"Bezdenezhnykh","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Blvd. 6, Kemerovo 650002, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4420-4350","authenticated-orcid":false,"given":"Andrey V.","family":"Bezdenezhnykh","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Blvd. 6, Kemerovo 650002, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya A.","family":"Kuzmina","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Blvd. 6, Kemerovo 650002, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6890-3287","authenticated-orcid":false,"given":"Yuliya A.","family":"Dyleva","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Blvd. 6, Kemerovo 650002, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga L.","family":"Barbarash","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Blvd. 6, Kemerovo 650002, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_2","first-page":"7","article-title":"Prognosis and Complications of Diabetic Patients Undergoing Isolated Coronary Artery Bypass Surgery","volume":"31","author":"Santos","year":"2016","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.17802\/2306-1278-2021-10-2-25-35","article-title":"Current trends in routine myocardial revascularization","volume":"10","author":"Ivanov","year":"2021","journal-title":"Complex Issues Cardiovasc. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.jtcvs.2021.05.035","article-title":"Impact of preoperative glycometabolic status on outcomes in cardiac surgery: Systematic review and meta-analysis","volume":"164","author":"Corazzari","year":"2022","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.115.015415","article-title":"Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death","volume":"132","author":"Selvin","year":"2015","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"108233","DOI":"10.1016\/j.diabres.2020.108233","article-title":"Review of methods for detecting glycemic disorders","volume":"165","author":"Bergman","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1932296814567227","article-title":"Advantages and Pitfalls of Fructosamine and Glycated Albumin in the Diagnosis and Treatment of Diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.numecd.2014.09.007","article-title":"Serum fructosamine and risk of cardiovascular and all-cause mortality: A 24-year prospective population-based study","volume":"25","author":"Zaccardi","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_10","first-page":"305","article-title":"Determination of the value of glycated hemoglobin HbA1c and fructosamine in assessing the risk of perioperative complications after cardiac surgery in patients with type 2 diabetes","volume":"13","author":"Rokicka","year":"2016","journal-title":"Kardiochirurgia Torakochirurgia Pol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1900\/RDS.2022.18.68","article-title":"1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events","volume":"18","year":"2022","journal-title":"Rev. Diabet. Stud."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"997649","DOI":"10.3389\/fcvm.2022.997649","article-title":"The clinical impact of serum 1,5-anhydro-D-glucitol levels on coronary artery calcification and adverse outcomes assessed by coronary optical coherence tomography in diabetic patients","volume":"9","author":"Teng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-017-0636-1","article-title":"Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0","volume":"16","author":"Ouchi","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12933-016-0459-5","article-title":"Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention","volume":"15","author":"Takahashi","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_15","unstructured":"World Health Organization (2006). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO\/IDF Consultation, World Health Organization."},{"key":"ref_16","unstructured":"International Diabetes Federation (2021). IDF Diabetes Atlas, International Diabetes Federation. [10th ed.]."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sumin, A.N., Bezdenezhnykh, N.A., Bezdenezhnykh, A.V., Osokina, A.V., Kuz\u2019mina, A.A., Tsepokina, A.V., and Barbarash, O.L. (2021). Screening for Glucose Metabolism Disorders, Assessment the Disse Insulin Resistance Index and Hospital Prognosis of Coronary Artery Bypass Surgery. J. Pers. Med., 11.","DOI":"10.3390\/jpm11080802"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2106\/JBJS.17.00075","article-title":"Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control","volume":"99","author":"Shohat","year":"2017","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1302\/0301-620X.101B7.BJJ-2018-1418.R1","article-title":"2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: A prospective multicentre study","volume":"101-B (Supple. C)","author":"Shohat","year":"2019","journal-title":"Bone Joint J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00380-015-0682-0","article-title":"Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention","volume":"31","author":"Fujiwara","year":"2016","journal-title":"Heart Vessel."},{"key":"ref_21","first-page":"e14031","article-title":"Effect of Acute Stress Glycemic Control and Long-Term Glycemic Control on the Incidence of Post-Operative Infection in Diabetics Undergoing Cardiac Surgery","volume":"13","author":"Bennett","year":"2021","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jtcvs.2021.06.004","article-title":"Commentary: Breaking the perioperative glucose control barrier is like breaking the sound barrier-it takes a team!","volume":"164","author":"Ferraris","year":"2022","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2022). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142022. Diabetes Care, 45, S17\u2013S38.","DOI":"10.2337\/dc22-S002"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/5\/969\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:47:13Z","timestamp":1760122033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/5\/969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["diagnostics13050969"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13050969","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]}}}